Search

everythinglearnresearchcommunity

for

Search:↓

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Fetal skin has unique immune cells different from adult skin.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Transplant success has improved with better immunosuppressive drugs and donor matching.